Garlic :: Stanford study drives stake through claims that garlic lowers
When it comes to lowering cholesterol levels, garlic stinks, according to a new study from the Stanford University School of Medicine.
When it comes to lowering cholesterol levels, garlic stinks, according to a new study from the Stanford University School of Medicine.
Many stroke patients have cholesterol higher than national guidelines recommend that, if managed, may have prevented the stroke from happening, according to a study published in the Feb. 27, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Reducing barnyard emissions is one way to help reduce the harmful effects of tiny atmospheric air particles that can cause severe asthma in children, and lung cancer and heart attacks in some adults.
The tiny Drosophila fruit fly may pave the way to new methods for studying and finding treatments for heart disease, the leading cause of death in industrialized countries, according to a collaborative study by the Burnham Institute for Medical Research, UC San Diego (UCSD) and the University of Michigan.
People who smoke have a greater risk of becoming infected with tuberculosis (TB) and of having that infection turn into active TB disease, according to an analysis by researchers at the University of California, Berkeley.
Dartmouth/VA researchers show that adding CRP testing to routine assessments would increase the number of Americans eligible for cholesterol-lowering treatment by about two million if used judiciously, and by over 25 million if used broadly — with most of these people being at low risk for heart attacks or heart disease.
Daiei Trading-Chicago-Co., Inc. of Carol Stream, Illinois is recalling 8.8 oz packages of Bean Cracker, “Itomo Mame Mix” because it contains undeclared peanuts.
A Georgetown medical professor cuts through hype surrounding weight-loss supplements with new science-based guide.
People who continuously participate in community groups are often spared losses in psychological well-being after developing functional limitations, according to an article published in the latest issue of the Journal of Gerontology: Social Sciences.
Bristol-Myers Squibb Company (NYSE: BMY) and Adnexus(TM) Therapeutics today announced a worldwide strategic alliance to discover, develop and commercialize Adnectin-based therapeutics for important oncology-related targets.